Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial
Francesco Di Pierro(University of Insubria), Nicola Zerbinati(University of Insubria), Giuseppe Derosa(University of Pavia), Muhammad Nabeel Akbar Chaudhry(Punjab Institute of Cardiology), Antonella Riva(Indena (Italy)), Amjad Khan(University of Michigan–Ann Arbor), Somia Iqtadar(King Edward Medical University), Pietro Allegrini(Indena (Italy)), Sami Ullah Mumtaz(King Edward Medical University), Alexander Bertuccioli(University of Urbino), Pamela Maffioli(University of Pavia), Martino Recchia, Stefano Togni(Indena (Italy))
Cited by 54
Related Papers
The Battle of the Water Sensor Networks (BWSN): A Design Challenge for Engineers and Algorithms
|Journal of Water Resources Planning and Management|2008|583
A 12-week treatment with fractional CO<sub>2</sub>laser for vulvovaginal atrophy: a pilot study
|Climacteric|2014|302
A role for quercetin in coronavirus disease 2019 (COVID‐19)
|Phytotherapy Research|2020|299
An Investigation on Preference Order Ranking Scheme for Multiobjective Evolutionary Optimization
|IEEE Transactions on Evolutionary Computation|2007|283